Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
Science · 10.11.2023 · 382 (6671)
DOI: 10.1126/science.abo7201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 10.11.2023. Verfasst von Melissa L Boby und 59 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Graduate Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Coronavirus 3C Proteases, SARS-CoV-2, Drug Discovery, Coronavirus Protease Inhibitors. Die Arbeit wurde bisher 188-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Wellcome Trust, NIA NIH HHS.
Abstract (Originalsprache)
We report the results of the COVID Moonshot, a fully open-science, crowdsourced, and structure-enabled drug discovery campaign targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease. We discovered a noncovalent, nonpeptidic inhibitor scaffold with lead-like properties that is differentiated from current main protease inhibitors. Our approach leveraged crowdsourcing, machine learning, exascale molecular simulations, and high-throughput structural biology and chemistry. We generated a detailed map of the structural plasticity of the SARS-CoV-2 main protease, extensive structure-activity relationships for multiple chemotypes, and a wealth of biochemical activity data. All compound designs (>18,000 designs), crystallographic data (>490 ligand-bound x-ray structures), assay data (>10,000 measurements), and synthesized molecules (>2400 compounds) for this campaign were shared rapidly and openly, creating a rich, open, and intellectual property–free knowledge base for future anticoronavirus drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmacology Graduate Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.
- Program in Chemical Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Program in Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK.
- Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK.
- Oxford Biomedical Research Centre, National Institute for Health Research, University of Oxford, Oxford, UK.
ORCID-Profile: Daren Fearon, Mihajlo Filep, Lizbé Koekemoer, Matthew C Robinson, John D Chodera, Nir London, Annette von Delft, Frank von Delft
Förderung
- NIGMS NIH HHS
- Wellcome Trust
- NIA NIH HHS
- NCI NIH HHS
Zitieren
APA
Boby, M. L., Fearon, D., Ferla, M., Filep, M., Koekemoer, L., Robinson, M. C., COVID Moonshot Consortium‡, Chodera, J. D., Lee, A. A., London, N., von Delft, A., von Delft, F., Achdout, H., Aimon, A., Alonzi, D. S., Arbon, R., Aschenbrenner, J. C., Balcomb, B. H., Bar-David, E., …, & Foster, R. (2023). Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382(6671). https://doi.org/10.1126/science.abo7201
Vancouver
Boby ML, Fearon D, Ferla M, Filep M, Koekemoer L, Robinson MC, et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science. 2023;382(6671). doi:10.1126/science.abo7201
BibTeX
@article{Boby2023,
author = {Boby, Melissa L and Fearon, Daren and Ferla, Matteo and Filep, Mihajlo and Koekemoer, Lizbé and Robinson, Matthew C and COVID Moonshot Consortium‡, COVID Moonshot Consortium‡ and Chodera, John D and Lee, Alpha A and London, Nir and von Delft, Annette and von Delft, Frank and Achdout, Hagit and Aimon, Anthony and Alonzi, Dominic S and Arbon, Robert and Aschenbrenner, Jasmin C and Balcomb, Blake H and Bar-David, Elad and Barr, Haim and Ben-Shmuel, Amir and Bennett, James and Bilenko, Vitaliy A and Borden, Bruce and Boulet, Pascale and Bowman, Gregory R and Brewitz, Lennart and Brun, Juliane and Bvnbs, Sarma and Calmiano, Mark and Carbery, Anna and Carney, Daniel W and Cattermole, Emma and Chang, Edcon and Chernyshenko, Eugene and Clyde, Austin and Coffland, Joseph E and Cohen, Galit and Cole, Jason C and Contini, Alessandro and Cox, Lisa and Croll, Tristan Ian and Cvitkovic, Milan and De Jonghe, Steven and Dias, Alex and Donckers, Kim and Dotson, David L and Douangamath, Alice and Duberstein, Shirly and Dudgeon, Tim and Dunnett, Louise E and Eastman, Peter and Erez, Noam and Eyermann, Charles J and Fairhead, Michael and Fate, Gwen and Fedorov, Oleg and Fernandes, Rafaela S and Ferrins, Lori and Foster, Richard},
title = {Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors},
journal = {Science},
year = {2023},
volume = {382},
number = {6671},
doi = {10.1126/science.abo7201}
}
EUVIMED